Chemomab Therapeutics (CMMB) Institutional Ownership $1.13 +0.03 (+2.73%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.16 +0.04 (+3.10%) As of 03/28/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.95MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$118.72K Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Remove Ads Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 XTX Topco Ltd24,929$45K0.0%+63.8%0.174% 2/11/2025 Virtu Financial LLC14,445$26K0.0%N/A0.101% 2/5/2025 Yelin Lapidot Holdings Management Ltd.744,127$1.35M0.2%-8.1%5.182% 11/15/2024 Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458% 2/1/2023 Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 2/14/2022 GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022 ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021 Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021 Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481% 11/3/2021 Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330% 9/17/2021 Virtu Financial LLC13,180$251K0.0%N/A0.116% 8/25/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386% 8/18/2021 Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370% 8/17/2021 Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380% 5/18/2021 Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021 Renaissance Technologies LLC7,023$202K0.0%N/A0.301% 5/6/2021 Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356% (Data available from 1/1/2016 forward)Remove Ads CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Yelin Lapidot Holdings Management Ltd. ($1.35M), and XTX Topco Ltd ($45K), Virtu Financial LLC ($26K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), Virtu Financial LLC ($14.45K), and XTX Topco Ltd ($9.71K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 1,238,726 shares in the last 24 months. This purchase volume represents approximately $1.95M in transactions. Which Chemomab Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Chemomab Therapeutics stock in the last 24 months: Yelin Lapidot Holdings Management Ltd. ($65.59K). How much institutional selling is happening at Chemomab Therapeutics? Institutional investors have sold a total of 65,590 shares in the last 24 months. This volume of shares sold represents approximately $118.72K in transactions. Related Companies IGMS Institutional Ownership ALGS Institutional Ownership ADAP Institutional Ownership ENTX Institutional Ownership IMAB Institutional Ownership EPIX Institutional Ownership SKYE Institutional Ownership SCLX Institutional Ownership IKNA Institutional Ownership UNCY Institutional Ownership This page (NASDAQ:CMMB) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMMB Stock Free CMMB Stock Alerts